Methods of Treating Inflammatory Bowel Disease.

机译：治疗炎症性肠病的方法。

获取原文

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Methods for treating intestinal inflammation by inhibiting Clostridium difficile toxin B-mediated activation of the epidermal growth factor receptor or by inhibiting Clostridium difficile toxin B-mediated activation of the extracellular signal-regulated kinase 1/2 are described.

著录项

作者
Pothoulakis, C.; LaMont, J. T.;
展开▼
作者单位

展开▼
年度 2005
页码 1-18
总页数 18
原文格式 PDF
正文语种
中图分类
关键词
Patent applications; Inhibitors; Gastrointestinal system; Bacterial diseases; Intestinal diesases; Toxins; Intestinal inflammation; Inflammatory bowel disease; Epidermal growth factor receptors; Extracellular signal-regulated kinase; Clostridium difficile toxin B-mediated activation;

机译：专利申请;抑制剂;胃肠系统;细菌性疾病;肠道疾病;毒素;肠道炎症;炎症性肠病;表皮生长因子受体;细胞外信号调节激酶;艰难梭菌毒素B介导的激活;

相似文献

外文文献
中文文献
专利

1. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. [J] . Van Assche G, Rutgeerts P American Journal of Physiology . 2005,第2期

机译：用于治疗炎症性肠病的新药疗法的生理基础。 I.抗粘附分子疗法在炎性肠病中的免疫学和治疗潜力。
2. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. [J] . Shanahan F American Journal of Physiology . 2005,第3期

机译：用于治疗炎性肠病的新药物疗法的生理学基础I.炎性肠病的益生菌治疗的病理生理学基础和前景。
3. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. [J] . Shanahan F American Journal of Physiology . 2005,第3期

机译：用于治疗炎性肠病的新药物疗法的生理学基础I.炎性肠病的益生菌治疗的病理生理学基础和前景。
4. Site-Directed Polymer-Drug Complexes for Modulating Gut Innate Immune System to Prevent/Treat Inflammatory Bowel Diseases(IBD) [C] . KesharwaniS., AhmadR., RajputM. Bioengineering and Translational Medicine Conference . 2018

机译：用于调节肠道先天免疫系统的部位定向聚合物 - 药物复合物，以预防/治疗炎症性肠病（IBD）
5. A study of risk factors associated with inflammatory bowel disease. [D] . Gibson, Tony S. 2017

机译：与炎症性肠病相关的危险因素的研究。
6. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. [O] . B J Dekker-Saeys, S G Meuwissen, E M Van Den Berg-Loonen, 1978

机译：强直性脊柱炎和炎症性肠病。三 50例强直性脊柱炎和炎性肠病患者的临床特征和组织相容性分型（HLA B27）结果。
7. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. [O] . Shanahan Fergus 2012

机译：用于治疗炎性肠病的新药物疗法的生理学基础I.炎性肠病的益生菌治疗的病理生理学基础和前景。

Methods of Treating Inflammatory Bowel Disease.

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅